SOURCE: Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc.

May 28, 2015 09:27 ET

Cocrystal Pharma to Present at Jefferies 2015 Global Healthcare Conference

Thursday, June 4, 2015, 12:30 ET at the Grand Hyatt, NYC

BOTHELL, WA and ATLANTA, GA--(Marketwired - May 28, 2015) - Cocrystal Pharma, Inc. (OTCQB: COCP), a company focused on developing novel antiviral therapeutics for human diseases, announced today that it will be presenting at the Jefferies 2015 Global Healthcare Conference on Thursday, June 4, 2015 from 12:30 p.m. to 1:00 p.m. at the Grand Hyatt in New York, New York.

Dr. Raymond F. Schinazi, Chairman of the Board of Directors and Jeffrey Meckler, Interim CEO will be presenting on behalf of the Company. A live webcast of the presentation can be accessed from the conference website at http://wsw.com/webcast/jeff88/cocp. A replay of the webcast will be archived on the Cocrystal website, www.cocrystalpharma.com, shortly after the event.

About Cocrystal Pharma
Cocrystal is a pharmaceutical company seeking to discover novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. Cocrystal employs unique technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. These technologies, including our nucleoside chemistry expertise and market-focused approach to drug discovery are designed to efficiently deliver small molecule therapeutics that are safe, effective and convenient to administer. The company has identified promising, preclinical stage compounds for hepatitis infections, and analogs that are effective against noroviruses. Cocrystal has previously received strategic investments from Teva Pharmaceuticals, OPKO Health (OPK), Dr. Raymond Schinazi, Brace Pharmaceutical, LLC, and The Frost Group. For further information about Cocrystal, please refer to www.cocrystalpharma.com.

Contact Information

  • MDM Worldwide
    David Zazoff
    212-643-0417